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Acetylacja chromatyny w ludzkich oocytach 
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 Abstract    
Objectives: The frequency of aneuploidies in human oocytes is extremely high. It is hypothesized that the cause 
may be due to abnormal chromatin (histone) acetylation/deacetylation. The aim of our study was to analyzed the 
acetylation/deacetylation pattern in spare human oocytes. 
Materials and Methods: Human spare oocytes (311), in other words oocytes that were not mature when col-
lected from follicles or control oocytes (bovine, mouse), were fixed with paraformaldehyde and then labeled with 
antibodies against acetylated histones. 
Results: Labeling against AcH4/K12 or hyperacetylated H4 showed high intensity of the fluorescence signal in all 
immature (germinal vesicle staged) and approximately 50% of the maturing (mature) oocytes. 
Conclusion: In conclusion, the labeling of human oocytes (chromosomes) showed very inconsistent patterns of 
acetylation/deacetylation, what may suggest they did not reach the metaphase II stage at the time of follicle aspi-
ration, and were epigenetically abnormal. It may also explain the high frequency of chromosomal abnormalities in 
human oocytes.
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 Streszczenie 
Cel: Częstość aneuploidii w ludzkich oocytach jest niezmiernie wysoka. Istnieją hipotezy, że jest to związane z 
nieprawidłową acetylacją/deacetylacją chromatyny (histonów). Celem badania była ocena wzoru acetylacji/deace-
tylacji w niewykorzystanych ludzkich oocytach.
Materiał i metoda: Ludzkie niewykorzystane oocyty (311), innymi słowy oocyty niedojrzałe w momencie pobrania 
z pęcherzyków lub oocyty kontrolne (krowie, mysie), zatopiono w paraformaldehydzie i oznakowano przeciwciałami 
przeciwko acetylowanym histonom.
Wyniki: Znakowanie przeciwko AcH4/K12 lub hiperacetylacja H4 wykazały wysoką częstość sygnału fluorescen-
cyjnego we wszystkich niedojrzałych (w stadium pęcherzyka germinalnego) i w około 50% dojrzałych oocytach.
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why	 human	 oocytes	 are	 so	 often	 chromosomally	 abnormal	 re-
mains	undiscovered.	In	fact,	the	basis	for	aneuploidies	can	be	es-
tablished	long	before	they	can	be	detected	in	fully	grown	oocytes	
[3].	Hunt	 and	Hassold	 [3]	 defined	 three	 developmental	 phases	
of	oogenesis	when	the	quality	of	oocytes	can	be	influenced	–	i/	
oogenesis,	ii/	follicle	formation	and	iii/	oocyte	growth	and	matu-




Highly	 dynamic	 morphological	 changes	 and	 specific	 histone	
modifications	 were	 reported	 to	 occur	 in	 mammalian	 oocytes	
within	that	 time	period.	An	immature	oocyte	contains	a	promi-
nent	 nucleus	 (germinal	 vesicle	 –	GV),	 in	which	 a	well-visible	
nucleolus	 can	 be	 seen	 in	 some	 species	 (rodents,	 humans,	 pig).	
A	germinal	vesicle	breakdown	(GVBD),	in	other	words	the	dis-
solution	of	GV	membrane,	disappearance	of	nucleoli	and	gradual	
condensation	 of	 chromatin,	 occurs	 following	 a	 gonadotropin	
surge	 or	 in	 in	 vitro	 cultures.	The	 condensed	 chromosomes	 are	
then	arranged	in	the	metaphase	I	stage	(MI)	with	a	well-formed	
spindle.	This	stage	is	followed	by	a	short	anaphase	to	telophase	








































Human	 oocytes,	 after	 standard	 stimulation,	were	 collected	






ian	 syndrome,	 anovulation,	 genetic	 factors,	male	 factors,	 etc.).	
The	mature	oocytes,	i.e.	the	metaphase	II	staged,	were	used	either	









The	oocytes	were	 then	kept	 in	PBS	at	4°C	until	 immunolabel-
ing.	Before	 labeling	 the	 oocytes	were	 permeabilized	 by	Triton	
X-100	(0.2%	in	PBS)	for	10min	and	then	blocked	overnight	in	
PBS	 supplemented	with	1%	BSA	 (bovine	 serum	albumin)	 and	
0.1%	 TritonX-100	 at	 4°C.	 The	 oocytes	 were	 then	 incubated	
overnight	with	one	of	 the	 following	 antibodies:	 anti-acetylated	




different	mammals	 (anti-acetylated	H4/K12).	Following	 the	 in-
cubation	with	one	of	the	above	mentioned	antibodies,	the	oocytes	
were	washed	several	times	in	PBS/BSA	and	then	incubated	for	2h	
Wnioski: Znakowanie ludzkich oocytów (chromosomów) wykazuje wysoce niejednoznaczny model acetylacji/de-
acetylacji, co może sugerować, że nie osiągają one metafazy II podziału w momencie aspiracji pęcherzyka i są 
epigenetycznie nieprawidłowe. Ten fakt może tłumaczyć wysoką częstość nieprawidłowości chromosomalnych w 
ludzkich oocytach.
 Słowa kluczowe: oocyt /dojrzewanie /chormosom /acetylacja /aneuploidia /
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positively	 labeled	 (95%;	 35/37).	About	 half	 of	 the	 metaphase	
I	 (48%;	40/83)	 and	 the	metaphase	 II	 (50%;	9/18)	was	positive	
when	this	antibody	was	used,	whilst	the	other	half	was	without	
labeling.	All	telophase	I	stage	oocytes	were	positively	labeled.	




vine,	 56	–	murine).	Surprisingly,	we	 found	 evident	 differences	
in	labeling	when	comparing	the	pattern	of	labeling	(AcH4/K12,	
anti-hyperacetylated	 H4)	 between	 oocytes	 obtained	 from	 the	







to	 evaluate	 the	 quality	 of	 oocytes	 and	 to	 explain	 the	 high	 fre-
quency	of	aneuploidies	in	them.
Discussion
The	 ovary	 contains	 basically	 three	 categories	 of	 oocytes:	
growing,	intermediate	and	full-grown.	Only	full-grown	oocytes	
can	 undergo	 germinal	 vesicle	 breakdown	 and	 reach	 the	 meta-
phase	 II	 stage	 [4].	This,	 however,	 does	not	mean	 that	 they	 are	
chromosomally	 normal	 and	 developmentally	 fully	 competent.	




labeled	 so	 far	with	 antibodies	 against	 acetylated	histones	were	
positive	[19,	20,	21],	but	the	use	of	these	antibodies	(anti-AcH4/
K12,	anti-hyperacetylated	H4)	also	indicates	that	the	extrapola-
tion	of	 the	 results	obtained	 in	 laboratory	and	domestic	animals	
to	 humans,	 in	 order	 to	 explain	 the	 frequency	 of	 aneuploidies,	
may	be	risky.	Essentially,	our	results	are	in	agreement	with	the	
observations	of	van	der	Berg	et	al.	[18],	who	found	that	all	im-
mature	 oocytes	 (GV)	 labeled	 with	 anti-AcH4/K12	 antibody	
and	 approximately	50%	of	MI	 and	MII	oocytes	were	positive.	
Moreover,	 detailed	 analyses	 demonstrate	 a	 positive	 correlation	
between	 positive	 labeling	 and	 abnormal	 spindle	 morphology.	
This	may	consequently	lead	to	unequal	distribution	of	the	chro-
mosomal	material,	either	during	the	exit	from	the	metaphase	I	or	
the	metaphase	 II.	Their	 results,	however,	also	show	that	 it	will	
be	difficult	to	find	any	relationship	between	the	acetylation	pat-
tern	and	aberrant	chromosome	segregation.	AcH4K12	seems	to	
be	 the	most	convenient	of	all	antibodies	 they	 tested	 (AcH4K5,	
AcH4K8,	AcH4K12,	AcH4K16).	These	authors	also	found	cer-
tain	 differences	 in	 labeling	 (AcH4/K12)	 between	 the	 oocytes	
Table I. Chromosone Acetylation in Human Oocytes.
Antibody
Oocyte maturation stage – No of oocytes (±; positive/negative labeling) [%]
GV MI A-TI MII
AcH4K12 105 (95/10) [95/10] 58 (27/31) [47/53] 2 (2/0) [100/0] 45 (22/23) [49/51]
HyperAcH4 37 (35/2) [95/5] 83 (40/43) [48/52] 3 (3/0) [100/0] 18 (9/9) [50/50]
Abbreviations: GV – germinal vesicle, MI(II) - metaphase I(II), A/TI – anaphase/telophase I, GV category involves both SN (surrounded nucleolus, approximately 60%) 
and NSN (non-surrounded nucleolus) oocytes. As no differences between these two groups were detected, the data were pooled.
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patients	with	 different	 fertility	 problems.	 Second,	we	 analyzed	





more	 competent	 than	 those	 oocytes	 in	 which	 maturation	 lasts	
longer	 [23].	 It	 has	 been	 also	 shown	 that	 certain	manipulations	
and	culture	conditions	influence	the	level	of	methylation	(global	
DNA	methylation	and/or	histone	acetylation)	in	embryos	[20,	24,	
14].	Essentially,	 the	 labeling	 intensity	 in	manipulated	 embryos	







It	 is	 fairy	difficult	 to	determine	 these	 issues	as	human	oo-
cytes	are	primarily	used	for	test	tube	babies	production	and	spare,	
high	quality	oocytes,	are	available	only	in	exceptional	situations.





Figure 1A.) Immature germinal vesicle stage human oocyte with the nucleolus 
surrounded by chromatin (arrow) labeled with anti-AcH4/K12 antibody. All oocytes 
showed the positive chromatin labeling. The same situation was observed after 
labeling with anti-hyperacetylated H4 antibody. x 400.
 




Figure 2A. Telophase I stage human oocyte with a weak chromosome groups 
(arrows) labeling (AcH4/K12). x 400.
 
Figure 2B. Parallel DAPI staining. 
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